Riverain Medical of Dayton, Ohio, announced that they have signed an agreement with group purchasing organization Amerinet.
Riverain's Rapid Screen has obtained FDA clearance for marketing as a chest radiography CAD system that is designed to assist radiologists in detecting suspicious pulmonary nodules that could indicate early-stage lung cancer. Amerinet will serve as a marketing partner for Riverain.
Under the agreement, Riverain Medical will provide RapidScreen to Amerinet members who include 35,000 acute care, non-acute care and integrated delivery networks, at a preferred rate. This contract is effective immediately and will extend for three years.